News Center

Home page

Peak Report

News reports

Meet the challenge at the peak

Release time:

2020-08-14

Meeting Challenges at Peak

■ Peak Pharmaceutical Zhang Mingyin

came to Peak Pharmaceutical Company from 2010 5# November. It has been eight years in an instant. In the past eight years, for me, four words can be summed up, that is, "learning while doing", constantly enriching myself and challenging myself.

My first position in a pharmaceutical company was in the quality assurance department. I still remember the first time I reported to the central laboratory, and the director asked me, "What did I do before?" I answered, "Workshop production management." The director said, "You should follow Xu Lizhen first when you go to work tomorrow..." In this way, Xu Lizhen, a small girl with serious and meticulous work, became my first master in the peak. Under her guidance, I started with the most basic physical and chemical tests and really started from scratch. It was midsummer, 10ml control bottle sampling, we climbed up and down the warehouse busy, everyone is a big sweat. By the end of summer, I was transferred to the then Jiangnan factory for process verification. The new master Qian Shenghua was a muscular boy like Tai Sen, but his work was still as meticulous and serious. Now, my two "little masters" have reached management positions, and batch after batch of young people have been continuously enriched to key positions. From them, I feel the tolerance and trust of the peak corporate culture, and also feel 60 -year-old peak full of vitality.

Working on intellectual property was another major challenge I took on at Spike Pharmaceuticals. In 2012 , I took over the related patent application maintenance and other intellectual property work originally undertaken by the Production Technology Department. In order to do this work well, In 2013 , I obtained the first intellectual property internal auditor qualification certificate from a pharmaceutical company, laying the foundation for a series of follow-up work. In 2014 , the trademark work of the former market planning department was also merged. The pharmaceutical company set up an intellectual property department and actively introduced the enterprise intellectual property management system. The burden on my shoulders became heavier and heavier. With the support and help of leaders and colleagues from various departments, in 2015 , Jianfeng Pharmaceutical's first company intellectual property management manual was completed and issued. 2016 successfully passed the third-party certification of the enterprise's intellectual property management system and was recognized as a national intellectual property advantage enterprise; In March of the same year 9, pharmaceutical Company No. 1050800 "Peak" Trademark (Class 5 ) was recognized as a well-known trademark in China by the State Administration for Industry and Commerce. In 2017 , Jianfeng Pharmaceutical won the honorary title of National Intellectual Property Demonstration Enterprise. This is the highest-level honor for national intellectual property work. When I heard this news, don't mention how proud I was.

In fact, before I took over, Jianfeng Pharmaceutical's intellectual property work had a very solid foundation. As early as

2012 , we were rated as Jinhua patent demonstration enterprise, and 2013 became Zhejiang patent demonstration enterprise. With this foundation, the subsequent implementation and benchmarking work also came naturally. At the same time, in the process of standardization, our relevant management became more standardized and orderly, and the level of intellectual property work has made great progress. As a specific participant in this work, I not only experienced my personal growth, but also gained several "firsts": 2015 , won the title of "advanced worker" for the first time; this year, it was recommended by Jinhua Municipal Science and Technology Bureau as an advanced individual of national intellectual property work enterprises.

Looking back at the peak of eight years, I deeply realize that here, we can have the opportunity to learn, have the opportunity to create, and have the opportunity to realize the integration of personal value and enterprise. This year, the 60th anniversary of Jianfeng Group's establishment and the 20th anniversary of the establishment of the pharmaceutical company. The eight years I have experienced are only a short part of the peak process. I did not have the opportunity to participate in the earlier past, but in the next ten years, I will be with the peak. With the same, I will confidently contribute my strength to the more brilliant peak

70rd anniversary.

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页